In Vitro Skin Sensitization Testing with Human Relevance and High Accuracy
In this webinar you will learn how combining genomics and machine learning provides a highly accurate in vitro method for assessment of skin sensitization hazard in medical device extracts, prepared according to ISO 10993-12.
What You Will Learn
Attendees will gain insights into:
- How GARD™skin Medical Device works and why it is highly accurate and human-relevant
- How to predict skin sensitizing hazard of materials by testing extractables directly using extraction solvents in accordance with ISO 10993:12
- How customers use the study results in different stages of the product life cycle, for safer products and in line with the 3Rs
Who Should Attend?
This webinar will benefit professionals working in the medical device industry, including:
- Decision Makers
- Safety Specialists
- Biocompatibility Experts
This will also be relevant to consultant companies and CROs specializing in biological evaluation and biocompatibility testing.
Dr Rose-Marie Jenvert: Product Manager GARD applications
Dr Joshua Schmidt: Business Development Director-Americas